Publication | Closed Access

A Randomized, Double-Blind, Dose-Finding, Multicenter, Phase 2 Study of Radium Chloride (Ra 223) in Patients with Bone Metastases and Castration-Resistant Prostate Cancer

Ra 223Radiation MedicineUrologyRadiation TherapyMedicineRadium ChlorideProstatic DiseasePhase 2OncologyRadiation Oncology